ArticlePlant biology (Stuttgart, Germany)2026
Chemical treatment rescues reduced growth of the autoimmune mutant chs3-2D without compromising its immune responses.
Article in Plant biology (Stuttgart, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Plant development in many species including Arabidopsis relies on the accurate balance between growth and defence. A high degree of plant immunity is often accompanied by reduced growth. On the one hand, this growth-defence trade-off depends on the redistribution of metabolic power to either growth or defence. On the other hand, its regulation requires distinct molecular signalling pathways. Reduced growth of the Arabidopsis autoimmune mutant chs3-2D, which shows strong resistance to pathogens, has been rescued by the addition of the low molecular weight compound Ro 8-4304. The application of Ro 8-4304, however, also resulted in a decrease of immune responses to wild-type levels. We applied chemical modification of Ro 8-4304 to identify a derivative that rescues growth of the autoimmune mutant chs3-2D without compromising it immune capacity. In a screening of Ro 8-4304 derivatives, removal of a fluorine atom resulted in the derivative Ro-A03 that rescued growth, but did not affect the increased immune gene expression in chs3-2D. In the presence of Ro-A03 chs3-2D seedlings showed wild-type-like growth, but were more resistant to bacterial pathogens than wild-type seedlings, in line with salicylic acid levels that were higher than in the absence of Ro-A03. We generated a compound by chemical modification that can efficiently rescue growth without decreasing the immune response of the chs3-2D autoimmune mutant.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.